| LTF | Recorded death | ||||||
---|---|---|---|---|---|---|---|---|
 | Crude | Adjusted | Crude | Adjusted | ||||
 | HR1 | 95% CI | aHR1,2 | 95% CI | HR1 | 95% CI | aHR1,2 | 95% CI |
Age category | Â | Â | Â | Â | Â | Â | Â | Â |
15-24Â yrs | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
25-39Â yrs | 0.78 | 0.72-0.85 | 0.77 | 0.72-0.83 | 1.2 | 1.10-1.30 | 1.11 | 1.02-1.21 |
40-49Â yrs | 0.70 | 0.62-0.79 | 0.67 | 0.60-0.75 | 1.39 | 1.25-1.55 | 1.30 | 1.14-1.48 |
50+ yrs | 0.74 | 0.60-0.91 | 0.67 | 0.54-0.81 | 1.54 | 1.38-1.73 | 1.61 | 1.42-1.83 |
Sex | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Female | 0.79 | 0.75-0.83 | 0.73 | 0.70-0.76 | 0.71 | 0.66-0.77 | 0.90 | 0.82-0.98 |
Religion | Â | Â | Â | Â | Â | Â | Â | Â |
Orthodox | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Muslim | 1.22 | 1.00-1.48 | 1.17 | 1.01-1.35 | 1.03 | 0.89-1.19 | 0.98 | 0.86-1.13 |
Protestant | 0.89 | 0.72-1.11 | 0.99 | 0.88-1.10 | 0.84 | 0.70-1.00 | 0.77 | 0.69-0.86 |
Other/Unknown | 1.20 | 1.01-1.43 | 0.91 | 0.80-1.03 | 1.15 | 0.87-1.53 | 0.88 | 0.70-1.10 |
Marital status | Â | Â | Â | Â | Â | Â | Â | Â |
Never Married | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Married/Living together | 0.63 | 0.58-0.67 | 0.67 | 0.63-0.71 | 0.8 | 0.68-0.95 | 0.84 | 0.75-0.95 |
Separated/Divorced | 0.83 | 0.77-0.89 | 0.90 | 0.84-0.96 | 0.92 | 0.78-1.09 | 1.02 | 0.87-1.19 |
Widowed | 0.68 | 0.63-0.73 | 0.78 | 0.71-0.86 | 0.76 | 0.66-0.88 | 0.92 | 0.79-1.06 |
Other/Unknown | 1.04 | 0.78-1.39 | 0.97 | 0.80-1.03 | 1.12 | 0.73-1.72 | 1.08 | 0.88-1.33 |
Education | Â | Â | Â | Â | Â | Â | Â | Â |
No Education | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Primary | 0.74 | 0.70-0.79 | 0.71 | 0.66-0.75 | 1.23 | 1.16-1.29 | 1.27 | 1.18-1.36 |
Secondary | 0.64 | 0.58-0.71 | 0.59 | 0.53-0.66 | 1.47 | 1.33-1.62 | 1.51 | 1.38-1.66 |
Tertiary | 0.53 | 0.47-0.59 | 0.48 | 0.42-0.55 | 1.43 | 1.24-1.66 | 1.57 | 1.38-177 |
Other/Unknown | 1.04 | 0.80-1.36 | 0.96 | 0.79-1.17 | 1.60 | 1.16-2.23 | 1.36 | 1.05-1.75 |
WHO Stage at ART initiation | Â | Â | Â | Â | Â | Â | Â | Â |
Stage I | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Stage II | 0.96 | 0.86-1.07 | 0.94 | 0.85-1.04 | 1.15 | 0.96-1.38 | 1.07 | 0.89-1.27 |
Stage III | 1.30 | 1.15-1.47 | 1.19 | 1.07-1.32 | 2.06 | 1.70-2.49 | 1.68 | 1.41-1.99 |
Stage IV | 1.80 | 1.48-2.18 | 1.60 | 1.38-1.85 | 4.25 | 3.26-5.52 | 2.98 | 2.32-3.84 |
Missing | 1.28 | 1.12-1.47 | 1.18 | 1.07-1.33 | 2.3 | 1.69-3.11 | 1.66 | 1.22-2.24 |
CD4+ cell count (cells/mm 3 ) at ART initiation | Â | Â | Â | Â | Â | Â | Â | Â |
<100 | 1.39 | 1.18-1.64 | 1.43 | 1.20-1.71 | 1.62 | 1.27-2.06 | 1.84 | 1.37-2.46 |
100-199 | 0.97 | 0.82-1.16 | 1.09 | 0.91-1.31 | 0.75 | 0.57-0.98 | 1.01 | 0.74-1.37 |
200-350 | 0.87 | 0.72-1.04 | 0.96 | 0.78-1.19 | 0.48 | 0.37-0.62 | 0.64 | 0.49-0.85 |
350+ | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Missing | 1.36 | 1.09-1.70 | 1.46 | 1.20-1.77 | 1.67 | 1.26-2.21 | 1.81 | 1.36-2.41 |
First ART regimen | Â | Â | Â | Â | Â | Â | Â | Â |
D4T-containing regimen | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
AZT-containing regimen | 0.86 | 0.75-0.98 | 0.76 | 0.67-0.85 | 0.75 | 0.64-0.88 | 0.79 | 0.69-0.91 |
TDF-containing regimen | 0.92 | 0.81-1.04 | 0.66 | 0.59-0.74 | 0.60 | 0.51-0.70 | 0.74 | 0.64-0.86 |
Other | 2.91 | 2.08-3.78 | 2.72 | 2.07-3.58 | 1.35 | 0.79-2.30 | 1.51 | 0.81-2.81 |
Change of ART regimen | 0.26 | 0.21-0.32 | 0.25 | 0.19-0.31 | 0.48 | 0.42-0.56 | 0.41 | 0.35-0.49 |
Enrollment year | Â | Â | Â | Â | Â | Â | Â | Â |
2006-2007 | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
2008-2009 | 1.05 | 0.96-1.14 | 1.05 | 0.95-1.14 | 0.58 | 0.49-0.69 | 0.69 | 0.60-0.78 |
2010-2011 | 1.15 | 1.00-1.33 | 1.27 | 1.15-1.40 | 0.67 | 0.62-0.74 | 0.62 | 0.50-0.75 |
Point of entry | Â | Â | Â | Â | Â | Â | Â | Â |
PITC | 1.33 | 1.24-1.41 | 1.25 | 1.20-1.31 | 1.19 | 1.05-1.35 | 1.05 | 0.92-1.19 |
VCT | 1 | reference | 1 | reference | 1 | reference | Â | Â |
Other Hospital/HC | 1.19 | 1.08-1.30 | 1.12 | 1.05-1.20 | 0.89 | 0.78-1.03 | 0.83 | 0.72-0.95 |
Community | 1.42 | 1.23-1.63 | 1.18 | 1.06-1.30 | 0.56 | 0.24-1.31 | 0.59 | 0.30-1.14 |
Unknown/missing | 1.20 | 1.07-1.34 | 1.10 | 1.01-1.19 | 1.08 | 0.90-1.30 | 1.14 | 1.05-1.24 |
Facility type | Â | Â | Â | Â | Â | Â | Â | Â |
Primary | 0.67 | 0.49-0.92 | 0.86 | 0.60-1.24 | 1.03 | 0.63-1.69 | 1.28 | 0.77-2.14 |
Secondary/tertiary | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Setting | Â | Â | Â | Â | Â | Â | Â | Â |
Urban city (25 sites) | 1 | reference | 1 | reference | 1 | reference | 1 | reference |
Semi-urban (21 sites) | 0.93 | 0.71-1.21 | 0.89 | 0.72-1.09 | 1.33 | 0.87-2.05 | 1.36 | 0.86-2.16 |
Rural(10 sites) | 0.67 | 0.49-0.92 | 0.66 | 0.51-0.85 | 2.06 | 1.35-3.16 | 1.92 | 1.16-3.18 |
CD4 testing on-site | 1.47 | 1.18-1.83 | 1.31 | 1.08-1.60 | 0.68 | 0.48-0.96 | 0.85 | 0.62-1.06 |